← 產業報告目錄
Neurovascular Interventional Devices Industry Research Report 2026
出版商 APO Research產業別 Medical Devices出版日期 2026-07-04頁數 124報告編號 APO-b9d5e19bdc
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Neurovascular Interventional Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Neurovascular Interventional Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Neurovascular Interventional Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Neurovascular Interventional Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Neurovascular Interventional Devices include Johnson & Johnson, Medtronic PLC, W.L. Gore & Associates, Terumo Corporation, Stryker Corporation, Penumbra, Inc., Microport Scientific Corporation, Merit Medical Systems, Inc. and Cardinal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Neurovascular Interventional Devices market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neurovascular Interventional Devices Market by Company
Johnson & Johnson
Medtronic PLC
W.L. Gore & Associates
Terumo Corporation
Stryker Corporation
Penumbra, Inc.
Microport Scientific Corporation
Merit Medical Systems, Inc.
Cardinal Health
Boston Scientific Corporation
Abbott Laboratories
Neurovascular Interventional Devices Segment by Type
Embolization Coils
Intrasaccular Devices
Intracranial Stents
Carotid Stents
Flow Diverters
Others
Neurovascular Interventional Devices Segment by Application
Ambulatory Surgical Centers
Hospitals
Clinics
Others
Neurovascular Interventional Devices Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurovascular Interventional Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurovascular Interventional Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurovascular Interventional Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Neurovascular Interventional Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Neurovascular Interventional Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Neurovascular Interventional Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Neurovascular Interventional Devices Market Size (2021-2032)
2.2.2 Global Neurovascular Interventional Devices Sales (2021-2032)
2.2.3 Global Neurovascular Interventional Devices Market Average Price (2021-2032)
2.3 Neurovascular Interventional Devices by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Embolization Coils
2.3.3 Intrasaccular Devices
2.3.4 Intracranial Stents
2.3.5 Carotid Stents
2.3.6 Flow Diverters
2.3.7 Others
2.4 Neurovascular Interventional Devices by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Ambulatory Surgical Centers
2.4.3 Hospitals
2.4.4 Clinics
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Neurovascular Interventional Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Neurovascular Interventional Devices Sales (k units) of Manufacturers (2021-2026)
3.3 Global Neurovascular Interventional Devices Revenue of Manufacturers (2021-2026)
3.4 Global Neurovascular Interventional Devices Average Price by Manufacturers (2021-2026)
3.5 Global Neurovascular Interventional Devices Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Neurovascular Interventional Devices, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Neurovascular Interventional Devices, Product Type & Application
3.8 Global Manufacturers of Neurovascular Interventional Devices, Established Date
3.9 Global Neurovascular Interventional Devices Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Johnson & Johnson
4.1.1 Johnson & Johnson Company Information
4.1.2 Johnson & Johnson Business Overview
4.1.3 Johnson & Johnson Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
4.1.4 Johnson & Johnson Neurovascular Interventional Devices Product Portfolio
4.1.5 Johnson & Johnson Recent Developments
4.2 Medtronic PLC
4.2.1 Medtronic PLC Company Information
4.2.2 Medtronic PLC Business Overview
4.2.3 Medtronic PLC Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Medtronic PLC Neurovascular Interventional Devices Product Portfolio
4.2.5 Medtronic PLC Recent Developments
4.3 W.L. Gore & Associates
4.3.1 W.L. Gore & Associates Company Information
4.3.2 W.L. Gore & Associates Business Overview
4.3.3 W.L. Gore & Associates Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
4.3.4 W.L. Gore & Associates Neurovascular Interventional Devices Product Portfolio
4.3.5 W.L. Gore & Associates Recent Developments
4.4 Terumo Corporation
4.4.1 Terumo Corporation Company Information
4.4.2 Terumo Corporation Business Overview
4.4.3 Terumo Corporation Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Terumo Corporation Neurovascular Interventional Devices Product Portfolio
4.4.5 Terumo Corporation Recent Developments
4.5 Stryker Corporation
4.5.1 Stryker Corporation Company Information
4.5.2 Stryker Corporation Business Overview
4.5.3 Stryker Corporation Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Stryker Corporation Neurovascular Interventional Devices Product Portfolio
4.5.5 Stryker Corporation Recent Developments
4.6 Penumbra, Inc.
4.6.1 Penumbra, Inc. Company Information
4.6.2 Penumbra, Inc. Business Overview
4.6.3 Penumbra, Inc. Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
4.6.4 Penumbra, Inc. Neurovascular Interventional Devices Product Portfolio
4.6.5 Penumbra, Inc. Recent Developments
4.7 Microport Scientific Corporation
4.7.1 Microport Scientific Corporation Company Information
4.7.2 Microport Scientific Corporation Business Overview
4.7.3 Microport Scientific Corporation Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Microport Scientific Corporation Neurovascular Interventional Devices Product Portfolio
4.7.5 Microport Scientific Corporation Recent Developments
4.8 Merit Medical Systems, Inc.
4.8.1 Merit Medical Systems, Inc. Company Information
4.8.2 Merit Medical Systems, Inc. Business Overview
4.8.3 Merit Medical Systems, Inc. Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Merit Medical Systems, Inc. Neurovascular Interventional Devices Product Portfolio
4.8.5 Merit Medical Systems, Inc. Recent Developments
4.9 Cardinal Health
4.9.1 Cardinal Health Company Information
4.9.2 Cardinal Health Business Overview
4.9.3 Cardinal Health Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Cardinal Health Neurovascular Interventional Devices Product Portfolio
4.9.5 Cardinal Health Recent Developments
4.10 Boston Scientific Corporation
4.10.1 Boston Scientific Corporation Company Information
4.10.2 Boston Scientific Corporation Business Overview
4.10.3 Boston Scientific Corporation Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Boston Scientific Corporation Neurovascular Interventional Devices Product Portfolio
4.10.5 Boston Scientific Corporation Recent Developments
4.11 Abbott Laboratories
4.11.1 Abbott Laboratories Company Information
4.11.2 Abbott Laboratories Business Overview
4.11.3 Abbott Laboratories Neurovascular Interventional Devices Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Abbott Laboratories Neurovascular Interventional Devices Product Portfolio
4.11.5 Abbott Laboratories Recent Developments
5 Global Neurovascular Interventional Devices Market Scenario by Region
5.1 Global Neurovascular Interventional Devices Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Neurovascular Interventional Devices Sales by Region: 2021-2032
5.2.1 Global Neurovascular Interventional Devices Sales by Region: 2021-2026
5.2.2 Global Neurovascular Interventional Devices Sales by Region: 2027-2032
5.3 Global Neurovascular Interventional Devices Revenue by Region: 2021-2032
5.3.1 Global Neurovascular Interventional Devices Revenue by Region: 2021-2026
5.3.2 Global Neurovascular Interventional Devices Revenue by Region: 2027-2032
5.4 North America Neurovascular Interventional Devices Market Facts & Figures by Country
5.4.1 North America Neurovascular Interventional Devices Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Neurovascular Interventional Devices Sales by Country (2021-2032)
5.4.3 North America Neurovascular Interventional Devices Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Neurovascular Interventional Devices Market Facts & Figures by Country
5.5.1 Europe Neurovascular Interventional Devices Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Neurovascular Interventional Devices Sales by Country (2021-2032)
5.5.3 Europe Neurovascular Interventional Devices Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Neurovascular Interventional Devices Market Facts & Figures by Country
5.6.1 Asia Pacific Neurovascular Interventional Devices Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Neurovascular Interventional Devices Sales by Country (2021-2032)
5.6.3 Asia Pacific Neurovascular Interventional Devices Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Neurovascular Interventional Devices Market Facts & Figures by Country
5.7.1 South America Neurovascular Interventional Devices Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Neurovascular Interventional Devices Sales by Country (2021-2032)
5.7.3 South America Neurovascular Interventional Devices Revenue by Country (2021-2032)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Neurovascular Interventional Devices Market Facts & Figures by Country
5.8.1 Middle East and Africa Neurovascular Interventional Devices Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Neurovascular Interventional Devices Sales by Country (2021-2032)
5.8.3 Middle East and Africa Neurovascular Interventional Devices Revenue by Country (2021-2032)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Neurovascular Interventional Devices Sales by Type (2021-2032)
6.1.1 Global Neurovascular Interventional Devices Sales by Type (2021-2032) & (k units)
6.1.2 Global Neurovascular Interventional Devices Sales Market Share by Type (2021-2032)
6.2 Global Neurovascular Interventional Devices Revenue by Type (2021-2032)
6.2.1 Global Neurovascular Interventional Devices Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Neurovascular Interventional Devices Revenue Market Share by Type (2021-2032)
6.3 Global Neurovascular Interventional Devices Price by Type (2021-2032)
7 Segment by Application
7.1 Global Neurovascular Interventional Devices Sales by Application (2021-2032)
7.1.1 Global Neurovascular Interventional Devices Sales by Application (2021-2032) & (k units)
7.1.2 Global Neurovascular Interventional Devices Sales Market Share by Application (2021-2032)
7.2 Global Neurovascular Interventional Devices Revenue by Application (2021-2032)
7.2.1 Global Neurovascular Interventional Devices Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Neurovascular Interventional Devices Revenue Market Share by Application (2021-2032)
7.3 Global Neurovascular Interventional Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Neurovascular Interventional Devices Value Chain Analysis
8.1.1 Neurovascular Interventional Devices Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Neurovascular Interventional Devices Production Mode & Process
8.2 Neurovascular Interventional Devices Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Neurovascular Interventional Devices Distributors
8.2.3 Neurovascular Interventional Devices Customers
9 Global Neurovascular Interventional Devices Analyzing Market Dynamics
9.1 Neurovascular Interventional Devices Industry Trends
9.2 Neurovascular Interventional Devices Industry Drivers
9.3 Neurovascular Interventional Devices Industry Opportunities and Challenges
9.4 Neurovascular Interventional Devices Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Neurovascular Interventional Devices Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Neurovascular Interventional Devices Sales (k units) of Manufacturers (2021-2026)
Table 7. Global Neurovascular Interventional Devices Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Neurovascular Interventional Devices Revenue of Manufacturers (2021-2026)
Table 9. Global Neurovascular Interventional Devices Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Neurovascular Interventional Devices Average Price (USD/unit) of Manufacturers (2021-2026)
Table 11. Global Neurovascular Interventional Devices Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Neurovascular Interventional Devices, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Neurovascular Interventional Devices, Product Type & Application
Table 14. Global Neurovascular Interventional Devices Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Neurovascular Interventional Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Johnson & Johnson Company Information
Table 19. Johnson & Johnson Business Overview
Table 20. Johnson & Johnson Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 21. Johnson & Johnson Neurovascular Interventional Devices Product Portfolio
Table 22. Johnson & Johnson Recent Developments
Table 23. Medtronic PLC Company Information
Table 24. Medtronic PLC Business Overview
Table 25. Medtronic PLC Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 26. Medtronic PLC Neurovascular Interventional Devices Product Portfolio
Table 27. Medtronic PLC Recent Developments
Table 28. W.L. Gore & Associates Company Information
Table 29. W.L. Gore & Associates Business Overview
Table 30. W.L. Gore & Associates Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 31. W.L. Gore & Associates Neurovascular Interventional Devices Product Portfolio
Table 32. W.L. Gore & Associates Recent Developments
Table 33. Terumo Corporation Company Information
Table 34. Terumo Corporation Business Overview
Table 35. Terumo Corporation Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 36. Terumo Corporation Neurovascular Interventional Devices Product Portfolio
Table 37. Terumo Corporation Recent Developments
Table 38. Stryker Corporation Company Information
Table 39. Stryker Corporation Business Overview
Table 40. Stryker Corporation Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 41. Stryker Corporation Neurovascular Interventional Devices Product Portfolio
Table 42. Stryker Corporation Recent Developments
Table 43. Penumbra, Inc. Company Information
Table 44. Penumbra, Inc. Business Overview
Table 45. Penumbra, Inc. Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 46. Penumbra, Inc. Neurovascular Interventional Devices Product Portfolio
Table 47. Penumbra, Inc. Recent Developments
Table 48. Microport Scientific Corporation Company Information
Table 49. Microport Scientific Corporation Business Overview
Table 50. Microport Scientific Corporation Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 51. Microport Scientific Corporation Neurovascular Interventional Devices Product Portfolio
Table 52. Microport Scientific Corporation Recent Developments
Table 53. Merit Medical Systems, Inc. Company Information
Table 54. Merit Medical Systems, Inc. Business Overview
Table 55. Merit Medical Systems, Inc. Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 56. Merit Medical Systems, Inc. Neurovascular Interventional Devices Product Portfolio
Table 57. Merit Medical Systems, Inc. Recent Developments
Table 58. Cardinal Health Company Information
Table 59. Cardinal Health Business Overview
Table 60. Cardinal Health Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 61. Cardinal Health Neurovascular Interventional Devices Product Portfolio
Table 62. Cardinal Health Recent Developments
Table 63. Boston Scientific Corporation Company Information
Table 64. Boston Scientific Corporation Business Overview
Table 65. Boston Scientific Corporation Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 66. Boston Scientific Corporation Neurovascular Interventional Devices Product Portfolio
Table 67. Boston Scientific Corporation Recent Developments
Table 68. Abbott Laboratories Company Information
Table 69. Abbott Laboratories Business Overview
Table 70. Abbott Laboratories Neurovascular Interventional Devices Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026)
Table 71. Abbott Laboratories Neurovascular Interventional Devices Product Portfolio
Table 72. Abbott Laboratories Recent Developments
Table 73. Global Neurovascular Interventional Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 74. Global Neurovascular Interventional Devices Sales by Region (2021-2026) & (k units)
Table 75. Global Neurovascular Interventional Devices Sales Market Share by Region (2021-2026)
Table 76. Global Neurovascular Interventional Devices Sales by Region (2027-2032) & (k units)
Table 77. Global Neurovascular Interventional Devices Sales Market Share by Region (2027-2032)
Table 78. Global Neurovascular Interventional Devices Revenue by Region (2021-2026) & (US$ Million)
Table 79. Global Neurovascular Interventional Devices Revenue Market Share by Region (2021-2026)
Table 80. Global Neurovascular Interventional Devices Revenue by Region (2027-2032) & (US$ Million)
Table 81. Global Neurovascular Interventional Devices Revenue Market Share by Region (2027-2032)
Table 82. North America Neurovascular Interventional Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 83. North America Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units)
Table 84. North America Neurovascular Interventional Devices Sales by Country (2027-2032) & (k units)
Table 85. North America Neurovascular Interventional Devices Revenue by Country (2021-2026) & (US$ Million)
Table 86. North America Neurovascular Interventional Devices Revenue by Country (2027-2032) & (US$ Million)
Table 87. Europe Neurovascular Interventional Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 88. Europe Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units)
Table 89. Europe Neurovascular Interventional Devices Sales by Country (2027-2032) & (k units)
Table 90. Europe Neurovascular Interventional Devices Revenue by Country (2021-2026) & (US$ Million)
Table 91. Europe Neurovascular Interventional Devices Revenue by Country (2027-2032) & (US$ Million)
Table 92. Asia Pacific Neurovascular Interventional Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 93. Asia Pacific Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units)
Table 94. Asia Pacific Neurovascular Interventional Devices Sales by Country (2027-2032) & (k units)
Table 95. Asia Pacific Neurovascular Interventional Devices Revenue by Country (2021-2026) & (US$ Million)
Table 96. Asia Pacific Neurovascular Interventional Devices Revenue by Country (2027-2032) & (US$ Million)
Table 97. South America Neurovascular Interventional Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 98. South America Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units)
Table 99. South America Neurovascular Interventional Devices Sales by Country (2027-2032) & (k units)
Table 100. South America Neurovascular Interventional Devices Revenue by Country (2021-2026) & (US$ Million)
Table 101. South America Neurovascular Interventional Devices Revenue by Country (2027-2032) & (US$ Million)
Table 102. Middle East and Africa Neurovascular Interventional Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 103. Middle East and Africa Neurovascular Interventional Devices Sales by Country (2021-2026) & (k units)
Table 104. Middle East and Africa Neurovascular Interventional Devices Sales by Country (2027-2032) & (k units)
Table 105. Middle East and Africa Neurovascular Interventional Devices Revenue by Country (2021-2026) & (US$ Million)
Table 106. Middle East and Africa Neurovascular Interventional Devices Revenue by Country (2027-2032) & (US$ Million)
Table 107. Global Neurovascular Interventional Devices Sales by Type (2021-2026) & (k units)
Table 108. Global Neurovascular Interventional Devices Sales by Type (2027-2032) & (k units)
Table 109. Global Neurovascular Interventional Devices Sales Market Share by Type (2021-2026)
Table 110. Global Neurovascular Interventional Devices Sales Market Share by Type (2027-2032)
Table 111. Global Neurovascular Interventional Devices Revenue by Type (2021-2026) & (US$ Million)
Table 112. Global Neurovascular Interventional Devices Revenue by Type (2027-2032) & (US$ Million)
Table 113. Global Neurovascular Interventional Devices Revenue Market Share by Type (2021-2026)
Table 114. Global Neurovascular Interventional Devices Revenue Market Share by Type (2027-2032)
Table 115. Global Neurovascular Interventional Devices Price by Type (2021-2026) & (USD/unit)
Table 116. Global Neurovascular Interventional Devices Price by Type (2027-2032) & (USD/unit)
Table 117. Global Neurovascular Interventional Devices Sales by Application (2021-2026) & (k units)
Table 118. Global Neurovascular Interventional Devices Sales by Application (2027-2032) & (k units)
Table 119. Global Neurovascular Interventional Devices Sales Market Share by Application (2021-2026)
Table 120. Global Neurovascular Interventional Devices Sales Market Share by Application (2027-2032)
Table 121. Global Neurovascular Interventional Devices Revenue by Application (2021-2026) & (US$ Million)
Table 122. Global Neurovascular Interventional Devices Revenue by Application (2027-2032) & (US$ Million)
Table 123. Global Neurovascular Interventional Devices Revenue Market Share by Application (2021-2026)
Table 124. Global Neurovascular Interventional Devices Revenue Market Share by Application (2027-2032)
Table 125. Global Neurovascular Interventional Devices Price by Application (2021-2026) & (USD/unit)
Table 126. Global Neurovascular Interventional Devices Price by Application (2027-2032) & (USD/unit)
Table 127. Key Raw Materials
Table 128. Raw Materials Key Suppliers
Table 129. Neurovascular Interventional Devices Distributors List
Table 130. Neurovascular Interventional Devices Customers List
Table 131. Neurovascular Interventional Devices Industry Trends
Table 132. Neurovascular Interventional Devices Industry Drivers
Table 133. Neurovascular Interventional Devices Industry Restraints
Table 134. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Neurovascular Interventional Devices Product Image
Figure 5. Global Neurovascular Interventional Devices Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Neurovascular Interventional Devices Market Size (2021-2032) & (US$ Million)
Figure 7. Global Neurovascular Interventional Devices Sales (2021-2032) & (k units)
Figure 8. Global Neurovascular Interventional Devices Average Price (USD/unit) & (2021-2032)
Figure 9. Embolization Coils Product Image
Figure 10. Intrasaccular Devices Product Image
Figure 11. Intracranial Stents Product Image
Figure 12. Carotid Stents Product Image
Figure 13. Flow Diverters Product Image
Figure 14. Others Product Image
Figure 15. Ambulatory Surgical Centers Product Image
Figure 16. Hospitals Product Image
Figure 17. Clinics Product Image
Figure 18. Others Product Image
Figure 19. Global Neurovascular Interventional Devices Revenue Share by Manufacturers in 2025
Figure 20. Global Manufacturers of Neurovascular Interventional Devices, Manufacturing Sites & Headquarters
Figure 21. Global Top 5 and 10 Neurovascular Interventional Devices Players Market Share by Revenue in 2025
Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 23. Global Neurovascular Interventional Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 24. Global Neurovascular Interventional Devices Sales by Region in 2025
Figure 25. Global Neurovascular Interventional Devices Revenue by Region in 2025
Figure 26. North America Neurovascular Interventional Devices Market Size by Country in 2025
Figure 27. North America Neurovascular Interventional Devices Sales Market Share by Country (2021-2032)
Figure 28. North America Neurovascular Interventional Devices Revenue Market Share by Country (2021-2032)
Figure 29. United States Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 30. Canada Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. Mexico Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. Europe Neurovascular Interventional Devices Market Size by Country in 2025
Figure 33. Europe Neurovascular Interventional Devices Sales Market Share by Country (2021-2032)
Figure 34. Europe Neurovascular Interventional Devices Revenue Market Share by Country (2021-2032)
Figure 35. Germany Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 36. France Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 37. U.K. Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 38. Italy Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Russia Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. Spain Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. Netherlands Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Switzerland Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. Sweden Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Poland Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Asia Pacific Neurovascular Interventional Devices Market Size by Country in 2025
Figure 46. Asia Pacific Neurovascular Interventional Devices Sales Market Share by Country (2021-2032)
Figure 47. Asia Pacific Neurovascular Interventional Devices Revenue Market Share by Country (2021-2032)
Figure 48. China Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 49. Japan Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. South Korea Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. India Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Australia Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 53. Taiwan Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 54. Southeast Asia Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 55. Southeast Asia Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. South America Neurovascular Interventional Devices Market Size by Country in 2025
Figure 57. South America Neurovascular Interventional Devices Sales Market Share by Country (2021-2032)
Figure 58. South America Neurovascular Interventional Devices Revenue Market Share by Country (2021-2032)
Figure 59. Brazil Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 60. Argentina Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 61. Chile Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 62. Middle East and Africa Neurovascular Interventional Devices Market Size by Country in 2025
Figure 63. Middle East and Africa Neurovascular Interventional Devices Sales Market Share by Country (2021-2032)
Figure 64. Middle East and Africa Neurovascular Interventional Devices Revenue Market Share by Country (2021-2032)
Figure 65. Egypt Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 66. South Africa Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 67. Israel Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 68. Türkiye Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 69. GCC Countries Neurovascular Interventional Devices Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 70. Global Neurovascular Interventional Devices Sales Market Share by Type (2021-2032)
Figure 71. Global Neurovascular Interventional Devices Revenue Market Share by Type (2021-2032)
Figure 72. Global Neurovascular Interventional Devices Price (USD/unit) by Type (2021-2032)
Figure 73. Global Neurovascular Interventional Devices Sales Market Share by Application (2021-2032)
Figure 74. Global Neurovascular Interventional Devices Revenue Market Share by Application (2021-2032)
Figure 75. Global Neurovascular Interventional Devices Price (USD/unit) by Application (2021-2032)
Figure 76. Neurovascular Interventional Devices Value Chain
Figure 77. Neurovascular Interventional Devices Production Mode & Process
Figure 78. Direct Comparison with Distribution Share
Figure 79. Distributors Profiles
Figure 80. Neurovascular Interventional Devices Industry Opportunities and Challenges
提及公司
Johnson & JohnsonMedtronic PLCW.L. Gore & AssociatesTerumo CorporationStryker CorporationPenumbra, Inc.Microport Scientific CorporationMerit Medical Systems, Inc.Cardinal HealthBoston Scientific CorporationAbbott Laboratories
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們